Literature DB >> 2292095

Diagnosis of obstructive sleep apnea.

H W Bonekat1, P E Krumpe.   

Abstract

The diagnosis of obstructive sleep apnea is frequently made by taking a meticulous history coupled with a high index of suspicion. Snoring and hypersomnolence are clinical features common to individuals with sleep apnea. Since snoring is said to be a "disease of listeners," it is not uncommon that bed partners reported an increased incidence of depression and marital displeasure. It is for this reason that the spouse or bed partner should be interviewed, since the patient may not be aware of any sleeping problems. Physicians should also be alert to complaints of excessive daytime somnolence, because studies have shown that patients with obstructive sleep apnea are at increased risk for automobile crashes. It has been estimated that approx 58,000 motor vehicle accidents involving people with sleep apnea will occur in the US each yr. By proper diagnosis and treatment, the physician is in a unique position to prevent at least some of the automobile accidents that result from falling asleep while driving. Polysomnography is the only definitive way to obtain a diagnosis of sleep apnea. This allows the physician not only to diagnosis the disorder, but also helps in the evaluation of the severity of the syndrome and selection of therapy. An ENT evaluation is also important in ruling out anatomic disorders that can cause upper airway obstruction. Certain factors, such as alcohol and sedative ingestion, may aggravate the condition in a person predisposed to sleep apnea, and subtle changes, such as unexplained hypertension, polycythemia, and cor pulmonale, should lead one to investigate the possibility of sleep apnea as the etiology.

Entities:  

Mesh:

Year:  1990        PMID: 2292095     DOI: 10.1007/bf02914445

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN: 0731-8235


  39 in total

Review 1.  Indications and standards for cardiopulmonary sleep studies. American Thoracic Society. Medical Section of the American Lung Association.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1989-02

Review 2.  Evaluation and diagnosis of sleep disorders patients.

Authors:  A Kales; J D Kales
Journal:  Semin Neurol       Date:  1987-09       Impact factor: 3.420

Review 3.  The physiology of the nose.

Authors:  J G Widdicombe
Journal:  Clin Chest Med       Date:  1986-06       Impact factor: 2.878

4.  Use of laryngeal sound recordings to monitor apnea.

Authors:  P E Krumpe; J M Cummiskey
Journal:  Am Rev Respir Dis       Date:  1980-11

5.  The effect of nasal packing on sleep-disordered breathing and nocturnal oxygen desaturation.

Authors:  V Taasan; J W Wynne; N Cassisi; A J Block
Journal:  Laryngoscope       Date:  1981-07       Impact factor: 3.325

6.  Undiagnosed sleep apnea in patients with essential hypertension.

Authors:  E C Fletcher; R D DeBehnke; M S Lovoi; A B Gorin
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

7.  Effect of intranasal obstruction on breathing during sleep.

Authors:  P M Suratt; B L Turner; S C Wilhoit
Journal:  Chest       Date:  1986-09       Impact factor: 9.410

8.  Snore-induced Mallory-Weiss syndrome.

Authors:  J R Merrill
Journal:  J Clin Gastroenterol       Date:  1987-02       Impact factor: 3.062

9.  Incidence of sleep apnea in a presumably healthy working population: a significant relationship with excessive daytime sleepiness.

Authors:  P Lavie
Journal:  Sleep       Date:  1983       Impact factor: 5.849

10.  The diagnosis of sleep-related breathing disorders.

Authors:  A M Romaker; S Ancoli-Israel
Journal:  Clin Chest Med       Date:  1987-03       Impact factor: 2.878

View more
  2 in total

1.  Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life.

Authors:  N McArdle; R Kingshott; H M Engleman; T W Mackay; N J Douglas
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

Review 2.  Severe upper airway obstruction during sleep.

Authors:  H William Bonekat; Kimberly A Hardin
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.